#Spain #Barcelona #Veeva #Indero #RTSM

Indero Marks 40th Study Live with Veeva RTSM

Indero, the clinical research organization also known as Innovaderm Research, proudly announces the successful launch of its 40th RTSM (Randomization and Trial Supply Management) study utilizing Veeva RTSM. This achievement represents a culmination of rigorous efforts in advancing clinical trial operations while ensuring the highest levels of efficiency and effectiveness.

A Step Forward in Clinical Trials

The adoption of Veeva RTSM technology has been transformative for Indero. The organization has strategically standardized its clinical trial processes with Veeva RTSM, which has not only enhanced operational capabilities but has also tailored their services to foster faster study timelines and greater process consistency. This innovative approach reflects Indero’s commitment to excellence, addressing the need for optimized processes in clinical trials.

Eric Hardy, Senior Director of Biometrics at Indero, stated, "As we continue to optimize our clinical trial operations, Veeva RTSM has driven more efficient processes and closer collaboration to ensure seamless execution. Because of this added speed and effectiveness, we can help bring therapies to market faster, allowing our sponsors, sites, and patients to benefit sooner."

The enhancement in workflow presents a significant advantage, as it allows for a better alignment of both organizational and patient needs—essential for successful clinical outcomes.

Partnership and Innovation

This milestone study underscores the ongoing collaboration between Indero and Veeva Systems. Since first implementing Veeva RTSM, Indero has continuously refined its operational practices to align with the cutting-edge solutions offered by Veeva. By creating standardized processes tailored to their specific needs, Indero is ensuring long-term success for its clinical trials.

Steve Simmerman, General Manager of Veeva RTSM, commented on the growing partnership. "With its enterprise standard RTSM approach, Indero is achieving greater long-term efficiency and reliability in their studies. Partnering with Indero to standardize clinical processes will further accelerate study timelines, demonstrating a streamlined approach that can advance the industry."

As the clinical research landscape evolves, the integration of advanced technology becomes increasingly important. Indero's thoughtful approach highlights how organizations can successfully implement these innovations to cater to an ever-demanding market.

Looking Ahead

Indero's achievement is a testament to the hard work and dedication of its team and the robust support provided by Veeva Systems. This successful launch sets a new benchmark within the industry, illustrating how strategic partnerships can lead to remarkable advancements in clinical research.

As both companies look toward the future, the emphasis remains on collaboration, efficiency, and quality, ensuring that all stakeholders—including researchers, sponsors, and patients—experience the benefits of faster and more effective clinical trials.

For more information on Veeva's enterprise standard RTSM and learnings from Indero's innovative strategies, visit Veeva's website.

Together, Indero and Veeva continue to drive the future of clinical trials, paving the way for advancements in therapeutic development and patient care.